Clinical Trial Update: Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis. [Phase 3]

View source ↗

Summary

A Phase 3 safety and efficacy trial evaluating two pancreatic enzyme formulations for exocrine pancreatic insufficiency in cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency

Drugs mentioned

• Pancreatic enzyme formulation A
• Pancreatic enzyme formulation B

Snippet

Sponsor: Forest Laboratories | Conditions: Exocrine Pancreatic Insufficiency: Cystic Fibrosis | Phase 3 | Status: COMPLETED